Postmenopausal Osteoporosis Treatment Global Market Report 2025

Description

Postmenopausal osteoporosis treatment refers to medical interventions and strategies aimed at managing and preventing bone loss and fractures in women after menopause. Postmenopausal osteoporosis is characterized by decreased bone density and an increased susceptibility to fractures due to hormonal changes after menopause.

The main types of drugs used in postmenopausal osteoporosis treatment include bisphosphonates, vitamin D3, estrogen agonists or antagonists, hormone replacement therapy, parathyroid hormone therapy, and others. Bisphosphonates, a class of medications, are commonly used to treat various bone-related conditions, with osteoporosis being a notable example. These medications can be administered through oral, parenteral, and other routes, and they are available through various distribution channels, including hospital pharmacies, retail pharmacies, and others.

The postmenopausal osteoporosis treatment market research report is one of a series of new reports from The Business Research Company that provides postmenopausal osteoporosis treatment market statistics, including postmenopausal osteoporosis treatment industry global market size, regional shares, competitors with a postmenopausal osteoporosis treatment market share, detailed postmenopausal osteoporosis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the postmenopausal osteoporosis treatment industry. This postmenopausal osteoporosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postmenopausal osteoporosis treatment market size has grown steadily in recent years. It will grow from $10.1 billion in 2024 to $10.58 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to aging population, hormone replacement therapy, increased awareness, fracture risk reduction, nutritional supplements

The postmenopausal osteoporosis treatment market size is expected to see strong growth in the next few years. It will grow to $13.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to healthcare infrastructure growth, increased screening programs, precision medicine approaches, biosimilars in osteoporosis treatment, bone health in women's health programs, digital health integration, regenerative medicine approaches. Major trends in the forecast period include diagnostic advances, new drug development, emerging therapies, collaborations for drug development, integration of ai.

The projected increase in osteoporosis prevalence is expected to drive the growth of the postmenopausal osteoporosis treatment market. Osteoporosis, characterized by reduced bone mass and weakened bone tissue, poses an increased risk of fractures. Postmenopausal osteoporosis treatment plays a crucial role in preventing or managing the condition, reducing fracture risks, and enhancing overall health outcomes. A report from Healthy Bones Australia revealed a rise in fractures related to osteoporosis or osteopenia from 178,439 in 2021 to 183,105 in 2022, emphasizing the need for effective postmenopausal osteoporosis treatments.

The rising prevalence of obesity is expected to drive the growth of the postmenopausal osteoporosis treatment market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat that can negatively affect health. Treatment for postmenopausal osteoporosis is particularly beneficial for individuals with obesity, as it helps increase bone density, reduce fracture risk, strengthen bones, and improve overall bone health by slowing down bone loss. This comprehensive health management can lead to a better quality of life by decreasing the risk of fractures, which significantly impacts mobility and independence. For example, in 2023, the Outdoor Industry Association (OIA), a U.S.-based non-profit, reported a 2.3% increase in outdoor recreation participants in 2022, reaching an all-time high of 168.1 million, which constitutes 55% of the U.S. population aged six and older. Thus, the growing prevalence of obesity is fueling the expansion of the postmenopausal osteoporosis treatment market.

Product innovations are emerging as a significant trend in the postmenopausal osteoporosis treatment market. Major companies in this sector are concentrating on developing innovative products, such as parathyroid hormone, to enhance efficacy and patient adherence. They are also investigating combination therapies and personalized medicine to improve treatment outcomes. Additionally, there is a strong emphasis on long-term safety studies and patient support programs to address concerns and encourage compliance. Parathyroid hormone (PTH) is produced by the parathyroid glands and plays a crucial role in regulating calcium levels in the blood. It promotes calcium release from bones, enhances reabsorption in the kidneys, and activates vitamin D to increase intestinal calcium absorption. For example, in November 2023, Apotex Corp., a pharmaceutical company based in Canada, launched teriparatide, a recombinant parathyroid hormone that significantly boosts bone mineral density and reduces fracture risk in individuals with osteoporosis. Its anabolic effects stimulate bone formation, making it an essential treatment for high-risk patients.

Major companies in the postmenopausal osteoporosis treatment market are striving to gain a competitive edge through innovative products. Advanced bone-building medications, typically administered through injections to promote bone health and density, are a focus of development. In November 2023, Teva Pharmaceuticals Inc., a U.S-based pharmaceutical company, received FDA approval for Forteo (teriparatide injection), catering to postmenopausal women with osteoporosis at high fracture risk. The approval underscores the significance of innovative bone-building medications in treating osteoporosis in both men and women.

Major companies operating in the postmenopausal osteoporosis treatment market include Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr.Reddys Laboratories Ltd., Hikma Pharmaceuticals PLC., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Takeda Pharmaceutical Company Limited, Lupin Limited, Ligand Pharmaceuticals Incorporated, Torrent Pharmaceuticals Limited.

North America was the largest region in the postmenopausal osteoporosis treatment market in 2024. The regions covered in the postmenopausal osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the postmenopausal osteoporosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The postmenopausal osteoporosis treatment market consists of revenues earned by entities by providing screening and diagnosis, bone density testing, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The postmenopausal osteoporosis treatment market also includes sales of selective estrogen receptor modulators and osteoporosis drugs that are used for the treatment of postmenopausal osteoporosis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postmenopausal Osteoporosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postmenopausal osteoporosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for postmenopausal osteoporosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The postmenopausal osteoporosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Bisphosphonates; Vitamin D3; Estrogen Agonist Or Antagonist; Hormone Replacement Therapy; Parathyroid Hormone Therapy; Other Drug Types
2) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Bisphosphonates: Alendronate; Risedronate; Zoledronic Acid
2) By Vitamin D3: Cholecalciferol; Ergocalciferol
3) By Estrogen Agonist Or Antagonist: Selective Estrogen Receptor Modulators (SERMs); Tamoxifen
4) By Hormone Replacement Therapy: Estrogen Therapy; Combined Estrogen-Progestin Therapy
5) By Parathyroid Hormone Therapy: Teriparatide; Abaloparatide
6) By Other Drug Types: Calcitonin; RANK Ligand Inhibitors
Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck and Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25226

1. Executive Summary

2. Postmenopausal Osteoporosis Treatment Market Characteristics

3. Postmenopausal Osteoporosis Treatment Market Trends And Strategies

4. Postmenopausal Osteoporosis Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Postmenopausal Osteoporosis Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Postmenopausal Osteoporosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Postmenopausal Osteoporosis Treatment Market Growth Rate Analysis
5.4. Global Postmenopausal Osteoporosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Postmenopausal Osteoporosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Postmenopausal Osteoporosis Treatment Total Addressable Market (TAM)

6. Postmenopausal Osteoporosis Treatment Market Segmentation

6.1. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bisphosphonates
Vitamin D3
Estrogen Agonist Or Antagonist
Hormone Replacement Therapy
Parathyroid Hormone Therapy
Other Drug Types
6.2. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Routes Of Administration
6.3. Global Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
6.4. Global Postmenopausal Osteoporosis Treatment Market, Sub-Segmentation Of Bisphosphonates, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alendronate
Risedronate
Zoledronic Acid
6.5. Global Postmenopausal Osteoporosis Treatment Market, Sub-Segmentation Of Vitamin D3, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cholecalciferol
Ergocalciferol
6.6. Global Postmenopausal Osteoporosis Treatment Market, Sub-Segmentation Of Estrogen Agonist Or Antagonist, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Estrogen Receptor Modulators (SERMs)
Tamoxifen: Selective Estrogen Receptor Modulators (SERMs)
Tamoxifen
6.7. Global Postmenopausal Osteoporosis Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Estrogen Therapy
Combined Estrogen-Progestin Therapy
6.8. Global Postmenopausal Osteoporosis Treatment Market, Sub-Segmentation Of Parathyroid Hormone Therapy, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Teriparatide
Abaloparatide
6.9. Global Postmenopausal Osteoporosis Treatment Market, Sub-Segmentation Of Other Drug Types, BY Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcitonin
RANK Ligand Inhibitors

7. Postmenopausal Osteoporosis Treatment Market Regional And Country Analysis

7.1. Global Postmenopausal Osteoporosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Postmenopausal Osteoporosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Postmenopausal Osteoporosis Treatment Market

8.1. Asia-Pacific Postmenopausal Osteoporosis Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Postmenopausal Osteoporosis Treatment Market

9.1. China Postmenopausal Osteoporosis Treatment Market Overview
9.2. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Postmenopausal Osteoporosis Treatment Market

10.1. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Postmenopausal Osteoporosis Treatment Market

11.1. Japan Postmenopausal Osteoporosis Treatment Market Overview
11.2. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Postmenopausal Osteoporosis Treatment Market

12.1. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Postmenopausal Osteoporosis Treatment Market

13.1. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Postmenopausal Osteoporosis Treatment Market

14.1. South Korea Postmenopausal Osteoporosis Treatment Market Overview
14.2. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Postmenopausal Osteoporosis Treatment Market

15.1. Western Europe Postmenopausal Osteoporosis Treatment Market Overview
15.2. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Postmenopausal Osteoporosis Treatment Market

16.1. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Postmenopausal Osteoporosis Treatment Market

17.1. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Postmenopausal Osteoporosis Treatment Market

18.1. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Postmenopausal Osteoporosis Treatment Market

19.1. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Postmenopausal Osteoporosis Treatment Market

20.1. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Postmenopausal Osteoporosis Treatment Market

21.1. Eastern Europe Postmenopausal Osteoporosis Treatment Market Overview
21.2. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Postmenopausal Osteoporosis Treatment Market

22.1. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Postmenopausal Osteoporosis Treatment Market

23.1. North America Postmenopausal Osteoporosis Treatment Market Overview
23.2. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Postmenopausal Osteoporosis Treatment Market

24.1. USA Postmenopausal Osteoporosis Treatment Market Overview
24.2. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Postmenopausal Osteoporosis Treatment Market

25.1. Canada Postmenopausal Osteoporosis Treatment Market Overview
25.2. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Postmenopausal Osteoporosis Treatment Market

26.1. South America Postmenopausal Osteoporosis Treatment Market Overview
26.2. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Postmenopausal Osteoporosis Treatment Market

27.1. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Postmenopausal Osteoporosis Treatment Market

28.1. Middle East Postmenopausal Osteoporosis Treatment Market Overview
28.2. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Postmenopausal Osteoporosis Treatment Market

29.1. Africa Postmenopausal Osteoporosis Treatment Market Overview
29.2. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Postmenopausal Osteoporosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Postmenopausal Osteoporosis Treatment Market Competitive Landscape And Company Profiles

30.1. Postmenopausal Osteoporosis Treatment Market Competitive Landscape
30.2. Postmenopausal Osteoporosis Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Postmenopausal Osteoporosis Treatment Market Other Major And Innovative Companies

31.1. Bayer AG
31.2. Novartis AG
31.3. Sanofi SA
31.4. Eli Lilly and Company
31.5. Amgen Inc.
31.6. Asahi Kasei Corporation
31.7. Viatris Inc.
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Mylan N.V.
31.10. Sandoz International GmbH
31.11. Fresenius Kabi AG
31.12. Daiichi Sankyo Company Ltd.
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Cipla Inc.
31.15. Dr.Reddys Laboratories Ltd.

32. Global Postmenopausal Osteoporosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Postmenopausal Osteoporosis Treatment Market

34. Recent Developments In The Postmenopausal Osteoporosis Treatment Market

35. Postmenopausal Osteoporosis Treatment Market High Potential Countries, Segments and Strategies

35.1 Postmenopausal Osteoporosis Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Postmenopausal Osteoporosis Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Postmenopausal Osteoporosis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer